2,840
Views
8
CrossRef citations to date
0
Altmetric
Other

Health Communication and Decision Making about Vaccine Clinical Trials during a Pandemic

ORCID Icon

References

  • Agency for Healthcare Research and Quality. (2015a). Health literacy universal precautions toolkit (2nd ed.). https://www.ahrq.gov/sites/default/files/publications/files/healthlittoolkit2_4.pdf
  • Agency for Healthcare Research and Quality. (2015b). Health literacy universal precautions toolkit, 2nd ed. Consider Culture, Customs, and Beliefs https://www.ahrq.gov/health-literacy/improve/precautions/tool10.html
  • Ajzen, I. (1985). From intentions to actions: A theory of planned behavior. In J. Kuhl & J. Beckmann (Eds.), Action control: from cognition to behavior (pp. 11–39). Springer Berlin Heidelberg, Germany. doi:10.1007/978-3-642-69746-3_2
  • Brehaut, J. C., O’Connor, A. M., Wood, T. J., Hack, T. F., Siminoff, L., Gordon, E., & Feldman-Stewart, D. (2003). Validation of a decision regret scale. Medical Decision Making, 23(4), 281–292. doi:10.1177/0272989X03256005
  • Burks, A. C., Doede, A., Showalter, S. L., & Keim-Malpass, J. (2020). Perceptions of clinical trial participation among women of varying health literacy levels. Oncology Nursing Forum, 47(3), 273–280. doi:10.1188/20.Onf.273-280
  • Byrne, M. M., Tannenbaum, S. L., Glück, S., Hurley, J., & Antoni, M. (2014). Participation in cancer clinical trials: Why are patients not participating? Medical Decision Making, 34(1), 116–126. doi:10.1177/0272989x13497264
  • Cameron, D., Willoughby, C., Messer, D., Lux, M., Aitken, M., & Getz, K. (2020). Assessing participation burden in clinical trials: introducing the patient friction coefficient. Clinical Therapeutics, 42(8), e150–e159. doi:10.1016/j.clinthera.2020.06.015
  • Carlisle, B., Kimmelman, J., Ramsay, T., & MacKinnon, N. (2015). Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. Clinical Trials (London, England), 12(1), 77–83. doi:10.1177/1740774514558307
  • CDC. (2020). CDC digital media toolkit: 2020-21 flu season. https://www.cdc.gov/flu/resource-center/toolkit/index.htm
  • Chou, W. S., & Budenz, A. (2020). Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun, 35(14), 1718–1722. doi:10.1080/10410236.2020.1838096
  • Clark, L. T., Watkins, L., Piña, I. L., Elmer, M., Akinboboye, O., Gorham, M., … Regnante, J. M. (2019). Increasing diversity in clinical trials: Overcoming critical barriers. Current Problems in Cardiology, 44(5), 148–172. doi:10.1016/j.cpcardiol.2018.11.002
  • Cohn, E. G., Jia, H., Smith, W. C., Erwin, K., & Larson, E. L. (2011). Measuring the process and quality of informed consent for clinical research: Development and testing. Oncology Nursing Forum, 38(4), 417–422. doi:10.1188/11.Onf.417-422
  • Cooper, L. A., & Williams, D. R. (2020). Excess deaths from COVID-19, community bereavement, and restorative justice for communities of color. JAMA, 324(15), 1491–1492.
  • COVID-19 Prevention Network. (2020). Clinical Studies. https://www.coronaviruspreventionnetwork.org/understanding-clinical-studies/
  • Craven, J. (2020). COVID-19 vaccine tracker. Regulatory Affairs Professionals Society. https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
  • Cutler, D. M., & Summers, L. H. (2020). The COVID-19 pandemic and the $16 trillion virus. JAMA, 324(15), 1495–1496. doi:10.1001/jama.2020.19759
  • Daley, M. F., Narwaney, K. J., Shoup, J. A., Wagner, N. M., & Glanz, J. M. (2018). Addressing parents’ vaccine concerns: A randomized trial of a social media intervention. American Journal of Preventive Medicine, 55(1), 44–54. doi:10.1016/j.amepre.2018.04.010
  • Detoc, M., Launay, O., Dualé, C., Mutter, C., Le Huec, J. C., Lenzi, N., … Botelho-Nevers, E. (2019). Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites. Vaccine, 37(44), 6633–6639. doi:10.1016/j.vaccine.2019.09.048
  • Dutta, M. J. (2007). Communicating about culture and health: Theorizing culture-centered and cultural sensitivity approaches. Communication Theory, 17(3), 304–328.
  • Dyer, O. (2020). Covid-19: Pharma companies promise not to bow to political pressure to rush vaccine production. BMJ, 370, m3512. doi:10.1136/bmj.m3512
  • Eggly, S., Barton, E., Winckles, A., Penner, L. A., & Albrecht, T. L. (2015). A disparity of words: Racial differences in oncologist-patient communication about clinical trials. Health Expectations, 18(5), 1316–1326. doi:10.1111/hex.12108
  • Egleston, B. L., Pedraza, O., Wong, Y. N., Dunbrack, R. L., Jr., Griffin, C. L., Ross, E. A., & Beck, J. R. (2015). Characteristics of clinical trials that require participants to be fluent in English. Clinical Trials (London, England), 12(6), 618–626. doi:10.1177/1740774515592881
  • Evangeli, M., Kafaar, Z., Kagee, A., Swartz, L., & Bullemor-Day, P. (2013). Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: An application of Prospect Theory. AIDS Care, 25(7), 910–914. doi:10.1080/09540121.2012.748163
  • Finset, A., Bosworth, H., Butow, P., Gulbrandsen, P., Hulsman, R. L., Pieterse, A. H., … van Weert, J. (2020). Effective health communication - a key factor in fighting the COVID-19 pandemic. Patient Education and Counseling, 103(5), 873–876. doi:10.1016/j.pec.2020.03.027
  • Frew, P. M., Kriss, J. L., Chamberlain, A. T., Malik, F., Chung, Y., Cortés, M., & Omer, S. B. (2016). A randomized trial of maternal influenza immunization decision-making: A test of persuasive messaging models. Human Vaccines & Immunotherapeutics, 12(8), 1989–1996. doi:10.1080/21645515.2016.1199309
  • Frew, P. M., Shapiro, E. T., Lu, L., Edupuganti, S., Keyserling, H. L., & Mulligan, M. J. (2013). Enrollment in YFV vaccine trial: an evaluation of recruitment outcomes associated with a randomized controlled double-blind trial of a live attenuated yellow fever vaccine. Tropical Medicine & Surgery, 1(2), 117. doi:10.4172/2329-9088.1000117
  • Getz, K., Sethuraman, V., Rine, J., Peña, Y., Ramanathan, S., & Stergiopoulos, S. (2019). Assessing patient participation burden based on protocol design characteristics. Therapeutic Innovation & Regulatory Science, 2168479019867284. doi:10.1177/2168479019867284
  • Giocos, G., Kagee, A., & Swartz, L. (2008). Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents. AIDS and Behavior, 12(6), 842–851. doi:10.1007/s10461-007-9289-5
  • Grady, C., Bedarida, G., Sinaii, N., Gregorio, M. A., & Emanuel, E. J. (2017). Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research. Clinical Trials (London, England), 14(5), 526–536. doi:10.1177/1740774517722130
  • Grantz, K. H., Claudot, P., Kambala, M., Kouyaté, M., Soumah, A., Boum, Y., … Grais, R. F. (2019). Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea. Vaccine, 37(48), 7165–7170. doi:10.1016/j.vaccine.2019.09.094
  • Hawkins, R. P., Kreuter, M., Resnicow, K., Fishbein, M., & Dijkstra, A. (2008). Understanding tailoring in communicating about health. Health Education Research, 23(3), 454–466. doi:10.1093/her/cyn004
  • Health Literacy Out Loud. (2014). Health literacy screening tools (HLOL #124). http://www.healthliteracyoutloud.com/?s=vital+sign
  • Health.gov. (2020). Health literacy in healthy people. https://health.gov/our-work/healthy-people-2030/about-healthy-people-2030/health-literacy-healthy-people
  • The History of Vaccines. (2018). Disease eradication. The College of Physicians of Philadelphia. https://www.historyofvaccines.org/content/articles/disease-eradication
  • Houghton, C., Dowling, M., Meskell, P., Hunter, A., Gardner, H., Conway, A., … Biesty, L. M. (2020). Factors that impact on recruitment to randomised trials in health care: A qualitative evidence synthesis. The Cochrane Database of Systematic Reviews, 10, Mr000045. doi:10.1002/14651858.MR000045.pub2
  • Hu, Y., Li, Q., & Chen, Y. (2018). Evaluation of two health education interventions to improve the varicella vaccination: A randomized controlled trial from a province in the east China. BMC Public Health, 18(1), 144. doi:10.1186/s12889-018-5070-0
  • Huang, G. D., Bull, J., Johnston McKee, K., Mahon, E., Harper, B., & Roberts, J. N. (2018). Clinical trials recruitment planning: A proposed framework from the clinical trials transformation Initiative. Contemporary Clinical Trials, 66, 74–79. doi:10.1016/j.cct.2018.01.003
  • Jaklevic, M. C. (2020). Researchers strive to recruit hard-hit minorities into COVID-19 vaccine trials. Jama, 324(9), 826–828. doi:10.1001/jama.2020.11244
  • Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020). Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology, 20(10), 615–632.
  • Joseph, G., & Dohan, D. (2009). Diversity of participants in clinical trials in an academic medical center: The role of the ‘good study patient?’. Cancer, 115(3), 608–615. doi:10.1002/cncr.24028
  • Kasting, M. L., Head, K. J., Cox, D., Cox, A. D., & Zimet, G. D. (2019). The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial. Preventive Medicine, 127, 105798. doi:10.1016/j.ypmed.2019.105798
  • Kim, E. S., Bruinooge, S. S., Roberts, S., Ison, G., Lin, N. U., Gore, L., … Schilsky, R. L. (2017). Broadening eligibility criteria to make clinical trials more representative: american society of clinical oncology and friends of cancer research joint research statement. Journal of Clinical Oncology, 35(33), 3737–3744. doi:10.1200/jco.2017.73.7916
  • Kreps, S., Prasad, S., Brownstein, J. S., Hswen, Y., Garibaldi, B. T., Zhang, B., & Kriner, D. L. (2020). Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Network Open, 3(10), e2025594. doi:10.1001/jamanetworkopen.2020.25594
  • Kreuter, M. W., Lukwago, S. N., Bucholtz, R. D., Clark, E. M., & Sanders-Thompson, V. (2003). Achieving cultural appropriateness in health promotion programs: Targeted and tailored approaches. Health Education & Behavior: The Official Publication of the Society for Public Health Education, 30(2), 133–146. doi:10.1177/1090198102251021
  • Krieger, J. L., Parrott, R. L., & Nussbaum, J. F. (2011). Metaphor use and health literacy: A pilot study of strategies to explain randomization in cancer clinical trials. Journal of Health Communication, 16(1), 3–16. doi:10.1080/10810730.2010.529494
  • Langford, A., & Bateman-House, A. (2020). Clinical trials for COVID-19: Populations most vulnerable to cOVID-19 must be included. Health Affairs Blog. https://www.healthaffairs.org/do/10.1377/hblog20200609.555007/full/
  • Langford, A., Studts, J. L., & Byrne, M. M. (2020). Improving knowledge and decision readiness to participate in cancer clinical trials: Effects of a plain language decision aid for minority cancer survivors. Patient Education and Counseling. doi:10.1016/j.pec.2020.07.005
  • Langford, A. T., Resnicow, K., & Beasley, D. D. (2015). Outcomes from the body & soul clinical trials project: A university-church partnership to improve African American enrollment in a clinical trial registry. Patient Education and Counseling, 98(2), 245–250. doi:10.1016/j.pec.2014.10.018
  • Langford, A. T., Resnicow, K., Dimond, E. P., Denicoff, A. M., Germain, D. S., McCaskill-Stevens, W., … Go, R. S. (2014). Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the national cancer institute’s community cancer centers program. Cancer, 120(6), 877–884. doi:10.1002/cncr.28483
  • MacDonald, N. E. (2015). Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33(34), 4161–4164. doi:10.1016/j.vaccine.2015.04.036
  • Mandava, A., Pace, C., Campbell, B., Emanuel, E., & Grady, C. (2012). The quality of informed consent: Mapping the landscape. A review of empirical data from developing and developed countries. Journal of Medical Ethics, 38(6), 356–365. doi:10.1136/medethics-2011-100178
  • Mattingly, W. A., Kelley, R. R., Wiemken, T. L., Chariker, J. H., Peyrani, P., Guinn, B. E., … Ramirez, J. (2015). Real-time enrollment dashboard for multisite clinical trials. Contemporary Clinical Trials Communications, 1, 17–21. doi:10.1016/j.conctc.2015.09.001
  • Michaud, J., Kates, J., Dolan, R., & Tolbert, J. (2020). States are getting ready to distribute COVID-19 vaccines. what do their plans tell us so far? Kaiser family foundation. https://www.kff.org/coronavirus-covid-19/issue-brief/states-are-getting-ready-to-distribute-covid-19-vaccines-what-do-their-plans-tell-us-so-far/
  • National Academies of Sciences, Engineering, and Medicine. (2020). Framework for equitable allocation of COVID-19 vaccine. National Academies Press, Washington, D.C. https://www.nap.edu/catalog/25917/framework-for-equitable-allocation-of-covid-19-vaccine
  • Neil, J. M., Gough, A., Kee, F., George, T. J., Jr., Pufahl, J., & Krieger, J. L. (2019). The influence of patient identification and narrative transportation on intentions to participate in cancer research. Journal of Cancer Education, 34(4), 725–734. doi:10.1007/s13187-018-1364-2
  • Nelson, D. E., Hesse, B. W., & Croyle, R. T. (2009). Making data talk: communicating public health data to the public, policy makers, and the press. Oxford University Press, United Kingdom. https://books.google.com/books?id=zwYpAQAAMAAJ
  • Nipp, R. D., Hong, K., & Paskett, E. D. (2019). Overcoming Barriers to Clinical Trial Enrollment. American Society of Clinical Oncology Educational Book., 39, 105–114. doi:10.1200/edbk_243729
  • O’Callaghan, K. P., Blatz, A. M., & Offit, P. A. (2020). Developing a SARS-CoV-2 vaccine at warp speed. JAMA, 324(5), 437–438. doi:10.1001/jama.2020.12190
  • O’Connor, A. M. (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25–30. doi:10.1177/0272989x9501500105
  • O’Leary, C., Casey, C., Webb, D., Collyar, D., & Pleasant, A. (2020). How health literacy can enhance the design and conduct of clinical trials from consent to conclusion. Studies in Health Technology and Informatics, 269, 275–284. doi:10.3233/shti200042
  • Palmer, S., Pudwell, J., Smith, G. N., & Reid, R. L. (2016). Optimizing participation of pregnant women in clinical trials: factors influencing decisions about participation in medication and vaccine trials. Journal of Obstetrics and Gynaecology Canada. Journal d’Obstétrique Et Gynécologie Du Canada, 38(10), 945–954. doi:10.1016/j.jogc.2016.04.100
  • Parkinson, B., Meacock, R., Sutton, M., Fichera, E., Mills, N., Shorter, G. W., … Bower, P. (2019). Designing and using incentives to support recruitment and retention in clinical trials: A scoping review and a checklist for design. Trials, 20(1), 624. doi:10.1186/s13063-019-3710-z
  • Patient-Centered Outcomes Research Institute. (2018). The Value of Engagement. https://www.pcori.org/engagement/value-engagement
  • Peng, W., Morgan, S. E., Mao, B., McFarlane, S. J., Occa, A., Grinfeder, G., & Byrne, M. M. (2019). Ready to make a decision: A model of informational aids to improve informed participation in clinical trial research. Journal of Health Communication, 24(12), 865–877. doi:10.1080/10810730.2019.1680773
  • Petty, R. E., & Cacioppo, J. T. (1986). The elaboration likelihood model of persuasion. In Richard E. Petty and John T. Cacioppo (Eds.), Communication and persuasion: Central and peripheral routes to attitude change (pp. 1–24). New York, NY: Springer. doi:10.1007/978-1-4612-4964-1_1
  • PlainLanguage.gov. (2020). What is plain language? https://www.plainlanguage.gov/about/definitions/
  • Polite, B. N., Cipriano-Steffens, T. M., Liao, C., Miller, E. L., Arndt, N. L., & Hahn, E. A. (2019). Investigation of a multimedia, computer-based approach to improve knowledge, attitudes, self-efficacy, and receptivity to cancer clinical trials among newly diagnosed patients with diverse health literacy skills. Cancer, 125(12), 2066–2075. doi:10.1002/cncr.31991
  • Politi, M. C., Kuzemchak, M. D., Kaphingst, K. A., Perkins, H., Liu, J., & Byrne, M. M. (2016). Decision aids can support cancer clinical trials decisions: Results of a randomized trial. Oncologist, 21(12), 1461–1470. doi:10.1634/theoncologist.2016-0068
  • Raheja, D., Davila, E. P., Johnson, E. T., Deović, R., Paine, M., & Rouphael, N. (2018). Willingness to participate in vaccine-related clinical trials among older adults. International Journal of Environmental Research and Public Health, 15, 8. doi:10.3390/ijerph15081743
  • Ratzan, S. C. (2011). Vaccine literacy: A new shot for advancing health. Journal of Health Communication, 16(3), 227–229. doi:10.1080/10810730.2011.561726
  • Ratzan, S. C., & Parker, R. M. 2000. Introduction. In National Library of Medicine currentbibliographies in medicine: Health literacy, edited by C. Selden, M. Zorn, S. Ratzan, & R. Parker. NLM Pub. No. CBM 2000-1. Bethesda, MD: National Institutes of Health.
  • Raviotta, J. M., Nowalk, M. P., Lin, C. J., Huang, H. H., & Zimmerman, R. K. (2016). Using Facebook™ to recruit college-age men for a human papillomavirus vaccine trial. American Journal of Men’s Health, 10(2), 110–119. doi:10.1177/1557988314557563
  • Resnicow, K., Baranowski, T., Ahluwalia, J. S., & Braithwaite, R. L. (1999). Cultural sensitivity in public health: Defined and demystified. Ethnicity and Disease, 9(1), 10–21.
  • Sastry, S., & Dutta, M. J. (2017). Health communication in the time of Ebola: A culture-centered interrogation. Journal of Health Communication, 22(sup1), 10–14. doi:10.1080/10810730.2016.1216205
  • Schmidt, H., Gostin, L. O., & Williams, M. A. (2020). Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines? JAMA, 324(20), 2023–2024. doi:10.1001/jama.2020.20571
  • Schultz, P. L., Carlisle, R., Cheatham, C., & O’Grady, M. (2017). Evaluating the use of plain language in a cancer clinical trial website/app. Journal of Cancer Education, 32(4), 707–713. doi:10.1007/s13187-016-0994-5
  • Sharma, A., Angel, L., & Bui, Q. (2015). Patient advisory councils: Giving patients a seat at the table. Family Practice Management, 22(4), 22–27.
  • Stratton, S. L., Spencer, H. J., Greenfield, W. W., Low, G., Hitt, W. C., Quick, C. M., … Nakagawa, M. (2015). A novel use of a statewide telecolposcopy network for recruitment of participants in a phase I clinical trial of a human papillomavirus therapeutic vaccine. Clinical Trials (London, England), 12(3), 199–204. doi:10.1177/1740774514566333
  • Street, R. L. (2003). Communication in medical encounters: An ecological perspective. In the Routledge Handbook of Health Communication (p. 65), T. Thompson, R. Parrott, A. Dorsey, & K. Miller (Eds.), Routledge, New York, NY. doi:10.4324/9781410607683
  • Tucker, C. M., Kang, S., Ukonu, N. A., Linn, G. S., DiSangro, C. S., Arthur, T. M., & Ralston, P. A. (2019). A Culturally sensitive church-based health-smart intervention for increasing health literacy and health-promoting behaviors among black adult churchgoers. Journal of Health Care for the Poor and Underserved, 30(1), 80–101. doi:10.1353/hpu.2019.0009
  • U.S. Department of Health & Human Services. (2020). Fact sheet: explaining operation warp speed. https://www.hhs.gov/coronavirus/explaining-operation-warp-speed/index.html
  • Unger, J. M., Vaidya, R., Hershman, D. L., Minasian, L. M., & Fleury, M. E. (2019). Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. Journal of the National Cancer Institute, 111(3), 245–255. doi:10.1093/jnci/djy221
  • Van Norman, G. A. (2020). “Warp speed” operations in the COVID-19 pandemic: moving too quickly? JACC. Basic to Translational Science, 5(7), 730–734. doi:10.1016/j.jacbts.2020.06.001
  • VanEpps, E. M., Volpp, K. G., & Halpern, S. D. (2016). A nudge toward participation: Improving clinical trial enrollment with behavioral economics. Science Translational Medicine, 8(348), 348fs313. doi:10.1126/scitranslmed.aaf0946
  • Wallerstein, N., Oetzel, J. G., Duran, B., Magarati, M., Pearson, C., Belone, L., … Dutta, M. J. (2019). Culture-centeredness in community-based participatory research: Contributions to health education intervention research. Health Education Research, 34(4), 372–388. doi:10.1093/her/cyz021
  • Wallington, S. F., Luta, G., Noone, A. M., Caicedo, L., Lopez-Class, M., Sheppard, V., … Mandelblatt, J. (2012). Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant latinos. Journal of Community Health, 37(2), 335–343. doi:10.1007/s10900-011-9450-y
  • Wendler, D., Kington, R., Madans, J., Van Wye, G., Christ-Schmidt, H., Pratt, L. A., … Emanuel, E. (2006). Are racial and ethnic minorities less willing to participate in health research? PLoS Medicine, 3(2), e19. doi:10.1371/journal.pmed.0030019
  • WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation. (2020). Placebo-controlled trials of Covid-19 vaccines — why we still need them. New England Journal of Medicine, 10.1056/NEJMp2033538.
  • World Health Organization. (2018). Vaccines: The powerful innovations bringing WHO’s mission to life every day. https://www.who.int/news-room/commentaries/detail/vaccines-the-powerful-innovations-bringing-who-s-mission-to-life-every-day
  • Yang, J., McComas, K., Gay, G., Leonard, J. P., Dannenberg, A. J., & Dillon, H. (2010). From information processing to behavioral intentions: Exploring cancer patients’ motivations for clinical trial enrollment. Patient Education and Counseling, 79(2), 231–238. doi:10.1016/j.pec.2009.08.010
  • Zimmer, C., Corum, J., & Wee, S.-L. (2020). Coronavirus Vaccine Tracker. New York Times. Retrieved November 29 2020 https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.